Evidence map›Paper›PMID 42979382›Full record

ReviewActa pharmaceutica Sinica. B2026

Coacervate-based materials as emerging vehicles for drug delivery.

Yapeng Xu, Hongling Zhu, Peter M Moyle, Yu Wan

Abstract readReview
In one paragraph

Review in Acta pharmaceutica Sinica. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yapeng XuSichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China.
Hongling ZhuSichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China.
Peter M MoyleSchool of Pharmacy and Pharmaceutical Sciences, The University of Queensland, Woolloongabba 4102, Queensland, Australia.
Yu WanSichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liquid-liquid phase separation (LLPS) is a fundamental mechanism for organizing intracellular biochemical reactions and mediating cellular responses to environmental cues. Inspired by natural membraneless condensates, coacervate-based materials have recently emerged as versatile platforms for drug delivery. Their ability to efficiently encapsulate diverse cargos and release them in response to external or physiological stimuli makes them highly promising for next-generation therapeutic delivery. Despite rapid progress, systematic understanding and design principles for coacervate-based delivery systems remain limited. A comprehensive elucidation of the intermolecular driving forces and mechanisms governing coacervate formation is therefore essential for their rational engineering. This review summarizes the fundamental principles underlying LLPS, fabrication strategies, and characterization techniques of coacervates, followed by recent advances in their applications for delivering small molecules and biomacromolecules. Finally, we discuss current challenges and future opportunities in developing multifunctional, stimuli-responsive coacervates with tunable physicochemical properties. Overall, this review provides insights into the molecular design of coacervate-based systems and highlights their potential in advancing nanomedicine and overcoming biological barriers in drug delivery.

Indexed as

Biomolecular condensatesCoacervateDrug delivery systemIntracellular deliveryLiquid dropletLiquid–liquid phase separationNanomedicineStimuli-responsive materials

Identifiers

PMID42979382
PMCPMC13729522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.